There were 1,685 press releases posted in the last 24 hours and 406,109 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Genticel Announces Publication in ‘Clinical Cancer Research’ of Phase 1 Trial Results Supporting Safety, Tolerability and Immunogenicity of GTL001

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.